Organicell Regenerative Medicine, Inc.

OCEL · OTC
Analyze with AI
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Operating Activities
Net Income-$5-$7-$9-$13
Dep. & Amort.$0$0$0$0
Deferred Tax$0-$0$0-$8
Stock-Based Comp.$4$3$4$9
Change in WC$0$1$1$1
Other Non-Cash-$1$0$0$8
Operating Cash Flow-$1-$2-$3-$3
Investing Activities
PP&E Inv.$0-$0-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$0$0$0
Inv. Sales/Matur.$0-$1$0$0
Other Inv. Act.-$0$1$0$0
Investing Cash Flow-$0$1-$1-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$0$7$3
Stock Repurch.$0-$1$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$8$3
Financing Cash Flow$0-$0$8$3
Forex Effect$0$0$0$0
Net Chg. in Cash-$1-$2$4-$0
Supplemental Information
Beg. Cash$2$4$0$1
End Cash$1$2$4$0
Free Cash Flow-$1-$2-$4-$3